1. ALK+ ALCL EVADES IMMUNE SURVEILLANCE THROUGH NPM-ALK-DRIVEN EPIGENETIC REPRESSION OF Cd48. (October 2022) Authors: Wu, R.; Sahasrabuddhe, A.; Ivan, E.; Shaw, T.; Mullighan, C.; Leventaki, V.; Elenitoba-Johnson, K.; Lim, M. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗